Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

33.93
+1.825.67%
Post-market: 33.930.00000.00%19:30 EDT
Volume:10K
Turnover:317.02K
Market Cap:34.51M
PE:-0.37
High:34.09
Open:32.77
Low:32.57
Close:32.11
52wk High:909.98
52wk Low:15.10
Shares:1.02M
Float Shares:860.30K
Volume Ratio:0.34
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-90.9250
EPS(LYR):-335.2669
ROE:-153.84%
ROA:-31.51%
PB:-0.98
PE(LYR):-0.10

Loading ...

Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Dec 23, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2023

Major Issues Report

Form 8-K - Current report